---
category: news
title: "Kiromic BioPharma Reports First Quarter 2021 Financial Results and Continued Corporate Progress"
excerpt: "Kiromic BioPharma achieved important scientific and operational milestones during the year that we believe have us well positioned for preparing our staff and our facilities for the first in-human dosing in Q3 2021,"
publishedDateTime: 2021-05-14T20:50:00Z
originalUrl: "https://www.businesswire.com/news/home/20210514005463/en/Kiromic-BioPharma-Reports-First-Quarter-2021-Financial-Results-and-Continued-Corporate-Progress"
webUrl: "https://www.businesswire.com/news/home/20210514005463/en/Kiromic-BioPharma-Reports-First-Quarter-2021-Financial-Results-and-Continued-Corporate-Progress"
type: article
quality: 0
heat: -1
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "BioXcel Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update"
    excerpt: "Granted FDA Breakthrough Therapy designation for BXCL501 for the acute treatment of agitation associated with dementia; registrational program"
    publishedDateTime: 2021-05-10T11:15:00Z
    webUrl: "https://markets.businessinsider.com/news/stocks/bioxcel-therapeutics-reports-first-quarter-2021-financial-results-and-provides-business-update-1030408520"
    type: article
    provider:
      name: Business Insider
      domain: businessinsider.com
    quality: 22
  - title: "Kiromic BioPharma Reports First Quarter 2021 Financial Results and Continued Corporate Progress"
    excerpt: "Kiromic BioPharma (NASDAQ: KRBP), a pre-clinical stage biotechnology company using its proprietary DIAMOND® artificial intelligence (“A.I.”) platform to improve drug discovery and development with a therapeutic focus on immune-oncology,"
    publishedDateTime: 2021-05-14T11:50:00Z
    webUrl: "https://www.morningstar.com/news/business-wire/20210514005463/kiromic-biopharma-reports-first-quarter-2021-financial-results-and-continued-corporate-progress"
    type: article
    provider:
      name: Morningstar, Inc.
      domain: morningstar.com
    quality: 0

secured: "4c7lPRZ4LcjSAC1z7cAyqOXoF9/Y2/EHWW6FPZrcYylI0wjw6kgBLWI5T0/VKt5m2yTPjo4o8rP6379EdKcEmjNrv6jzjora2mQy5Q3ANOyjfS3XGmMExVKvkJngZcQU6Ecqc6EjUT2OrFrXG2WBFpHHO/dr09wBlmVMQcXaw+KQAdvJvO+tqxRiPTX5IaKgebEfGV6kuSYgG1eRnZ2YT3mqSHQYBd9oOo6+2BXoCA3apWTGTeQGIIvoH4t80ePe36Ymc0zZdZEb3RXLZ5Eh8Tigf9RaIN5irR1TGOncsRO5VeKuY63dlMLI1/0z5TCM0RyCF98WOY87wVBI5y3PnDQVaQmuYjLo9mX8EvmwdTk=;+sTnoM46cV2vA/DqHfZhoQ=="
---

